Your browser doesn't support javascript.
loading
Long-term follow-up of a randomized AAV2-GAD gene therapy trial for Parkinson's disease.
Niethammer, Martin; Tang, Chris C; LeWitt, Peter A; Rezai, Ali R; Leehey, Maureen A; Ojemann, Steven G; Flaherty, Alice W; Eskandar, Emad N; Kostyk, Sandra K; Sarkar, Atom; Siddiqui, Mustafa S; Tatter, Stephen B; Schwalb, Jason M; Poston, Kathleen L; Henderson, Jaimie M; Kurlan, Roger M; Richard, Irene H; Sapan, Christine V; Eidelberg, David; During, Matthew J; Kaplitt, Michael G; Feigin, Andrew.
Affiliation
  • Niethammer M; Center for Neurosciences, The Feinstein Institute for Medical Research, Manhasset, New York, USA.
  • Tang CC; Center for Neurosciences, The Feinstein Institute for Medical Research, Manhasset, New York, USA.
  • LeWitt PA; Parkinson's Disease and Movement Disorders Program, Henry Ford Hospital, West Bloomfield, Michigan, USA; Department of Neurology, Wayne State University School of Medicine, Detroit, Michigan, USA.
  • Rezai AR; Department of Neurological Surgery, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Leehey MA; Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Ojemann SG; Department of Neurology, University of Colorado School of Medicine, Aurora, Colorado, USA.
  • Flaherty AW; Department of Neurology and.
  • Eskandar EN; Department of Neurology and.
  • Kostyk SK; Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Sarkar A; Department of Neurological Surgery, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Siddiqui MS; Department of Neurosurgery, Geisinger Health System, Danville, Pennsylvania, USA.
  • Tatter SB; Department of Neurology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
  • Schwalb JM; Department of Neurology, Wake Forest School of Medicine, Winston-Salem, North Carolina, USA.
  • Poston KL; Movement Disorder & Comprehensive Epilepsy Centers, Henry Ford Medical Group, West Bloomfield, Michigan, USA.
  • Henderson JM; Department of Neurology and Neurological Sciences and.
  • Kurlan RM; Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA.
  • Richard IH; Department of Neurosurgery, Stanford University School of Medicine, Stanford, California, USA.
  • Sapan CV; Neurology, The Center for Neurological and Neurodevelopmental Health, Voorhees, New Jersey, USA.
  • Eidelberg D; Department of Neurology and Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
  • During MJ; Asana Medical Inc., Miami Lakes, Florida, USA.
  • Kaplitt MG; Center for Neurosciences, The Feinstein Institute for Medical Research, Manhasset, New York, USA.
  • Feigin A; Department of Neurological Surgery, The Ohio State University College of Medicine, Columbus, Ohio, USA.
JCI Insight ; 2(7): e90133, 2017 04 06.
Article in En | MEDLINE | ID: mdl-28405611
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Genetic Therapy / Glutamate Decarboxylase Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Parkinson Disease / Genetic Therapy / Glutamate Decarboxylase Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Year: 2017 Type: Article